Giulia Baciarello

1.3k total citations
40 papers, 572 citations indexed

About

Giulia Baciarello is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Giulia Baciarello has authored 40 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Giulia Baciarello's work include Prostate Cancer Treatment and Research (19 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer, Lipids, and Metabolism (7 papers). Giulia Baciarello is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer, Lipids, and Metabolism (7 papers). Giulia Baciarello collaborates with scholars based in France, Italy and United States. Giulia Baciarello's co-authors include Karim Fizazi, Yohann Loriot, Laurence Albigès, Christophe Massard, Nicholas Pavlidis, Elie Rassy, Stergios Boussios, Bernard Escudier, Anna Patrikidou and Pernelle Lavaud and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Drugs.

In The Last Decade

Giulia Baciarello

38 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Baciarello France	15	326	272	114	107	92	40	572
Sang Hoon Chun South Korea	16	237 0.7×	178 0.7×	141 1.2×	33 0.3×	193 2.1×	54	564
Anne-Marie Ruppert France	14	400 1.2×	534 2.0×	90 0.8×	69 0.6×	175 1.9×	51	777
Milena Perez Mak Brazil	12	399 1.2×	234 0.9×	137 1.2×	43 0.4×	189 2.1×	34	664
Kuniaki Katsui Japan	17	251 0.8×	452 1.7×	69 0.6×	19 0.2×	51 0.6×	79	736
Andréa Moretti Italy	14	208 0.6×	286 1.1×	28 0.2×	32 0.3×	58 0.6×	36	650
Sandra M. E. Geurts Netherlands	14	293 0.9×	176 0.6×	169 1.5×	39 0.4×	95 1.0×	59	612
Holger G. Hass Germany	13	384 1.2×	208 0.8×	86 0.8×	134 1.3×	115 1.3×	40	644
Kai‐Keen Shiu United Kingdom	11	861 2.6×	215 0.8×	201 1.8×	425 4.0×	108 1.2×	36	1.1k
Carlo Furlan Italy	13	180 0.6×	252 0.9×	113 1.0×	28 0.3×	69 0.8×	29	515
Josef Kovařík United Kingdom	10	169 0.5×	139 0.5×	39 0.3×	23 0.2×	62 0.7×	42	449

Countries citing papers authored by Giulia Baciarello

Since Specialization

Citations

This map shows the geographic impact of Giulia Baciarello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Baciarello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Baciarello more than expected).

Fields of papers citing papers by Giulia Baciarello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Baciarello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Baciarello. The network helps show where Giulia Baciarello may publish in the future.

Co-authorship network of co-authors of Giulia Baciarello

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Baciarello. A scholar is included among the top collaborators of Giulia Baciarello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Baciarello. Giulia Baciarello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aprikian, Armen, et al.. (2025). Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings. Frontiers in Oncology. 15. 1491314–1491314. 1 indexed citations

Auclin, Édouard, Anna Patrikidou, Laura Mezquita, et al.. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 15(4). 1066–1066. 10 indexed citations

Baciarello, Giulia, et al.. (2023). Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. Cancer Drug Resistance. 6(3). 517–46. 10 indexed citations

Giannatempo, Patrizia, Valentina Guadalupi, Laura Marandino, et al.. (2023). Activity of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: Interim results from the phase 2 ARCADIA trial.. Journal of Clinical Oncology. 41(16_suppl). 4578–4578. 4 indexed citations

Pauli, Chantal, Tilmann Bochtler, Linda Mileshkin, et al.. (2021). A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience. The Oncologist. 26(5). e769–e779. 38 indexed citations

Olivier, Timothée, Eugenio Fernández, Sana Intidhar Labidi‐Galy, et al.. (2021). Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?. Cancer Treatment Reviews. 97. 102204–102204. 26 indexed citations

Charles, Cécile, Antonio Di Meglio, Mónica Arnedos, et al.. (2021). QualFatigue study: which factors influence the use of specific interventions for breast cancer survivors with fatigue? A cross-sectional exploratory study. Supportive Care in Cancer. 29(8). 4827–4834. 3 indexed citations

Colomba, Émeline, Grégoire Marret, Giulia Baciarello, et al.. (2020). Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome. European Journal of Cancer. 129. 117–122. 11 indexed citations

Rassy, Elie, et al.. (2020). New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?. Critical Reviews in Oncology/Hematology. 147. 102882–102882. 72 indexed citations

10.

Dumont, Clément, Giulia Baciarello, Pernelle Lavaud, et al.. (2020). Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial. Clinical Genitourinary Cancer. 18(6). 444–451. 6 indexed citations

11.

Ross, Jeffrey S., Ethan S. Sokol, Holger Moch, et al.. (2020). Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design. The Oncologist. 26(3). e394–e402. 44 indexed citations

12.

Lavaud, Pernelle, Giulia Baciarello, & Karim Fizazi. (2019). Principes de prise en charge des tumeurs germinales testiculaires métastatiques. Bulletin du Cancer. 106(10). 896–902. 1 indexed citations

13.

Krämer, Alwin, Ferrán Losa, Laurie M. Gay, et al.. (2018). Genomic profiling of carcinomas of unknown primary (CUP) to support clinical decisions.. Journal of Clinical Oncology. 36(15_suppl). e24162–e24162. 2 indexed citations

14.

Thibault, Constance, Jean‐Christophe Eymard, Alison Birtle, et al.. (2018). Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer. European Journal of Cancer. 97. 41–48. 7 indexed citations

15.

Hamilou, Zineb, Giulia Baciarello, & Karim Fizazi. (2017). Treatment of Castration-naive Metastatic Prostate Cancer. European Urology Focus. 3(6). 518–521. 2 indexed citations

16.

Cabel, Luc, Gwénaëlle Gravis, Pernelle Lavaud, et al.. (2017). Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients. Journal for ImmunoTherapy of Cancer. 5(1). 31–31. 44 indexed citations

17.

Obéric, Lucie, Christophe Massard, Gwénaël Le Teuff, et al.. (2016). Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours. European Journal of Cancer. 69. 151–157. 29 indexed citations

18.

Fuerea, Alina, Giulia Baciarello, Anna Patrikidou, et al.. (2016). Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors. European Journal of Cancer. 61. 44–51. 43 indexed citations

19.

Baciarello, Giulia & Cora N. Sternberg. (2016). Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide. Critical Reviews in Oncology/Hematology. 106. 14–24. 11 indexed citations

20.

Gabrielli, Roberto, Maria Sofia Rosati, Giulia Baciarello, et al.. (2012). Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery. 56(6). 1598–1605. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact